These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 22052270

  • 1. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ.
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
    Talarico-Filho S, Mendonça DO Nascimento M, Sperandeo DE Macedo F, DE Sanctis Pecora C.
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M, Lowe NJ, Kumar CR, Hamm H, Hyperhidrosis Clinical Investigators Group.
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis.
    Simonetta Moreau M, Cauhepe C, Magues JP, Senard JM.
    Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812
    [Abstract] [Full Text] [Related]

  • 5. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT.
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [Abstract] [Full Text] [Related]

  • 6. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J, Simonart T.
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [Abstract] [Full Text] [Related]

  • 7. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
    Lecouflet M, Leux C, Fenot M, Célerier P, Maillard H.
    J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
    [Abstract] [Full Text] [Related]

  • 8. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study.
    Bechara FG, Sand M, Altmeyer P, Sand D, Hoffmann K.
    Ann Plast Surg; 2007 Mar; 58(3):299-302. PubMed ID: 17471136
    [Abstract] [Full Text] [Related]

  • 9. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J, Kramer G, Jakse G.
    BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
    [Abstract] [Full Text] [Related]

  • 10. [Botulinum toxin in the treatment of focal hyperhidrosis].
    Schnider P, Moraru E, Kittler H, Voller B, Kranz G, Auff E.
    Wien Klin Wochenschr; 2001 Sep; 113 Suppl 4():36-41. PubMed ID: 15506051
    [Abstract] [Full Text] [Related]

  • 11. Treatment of axillary hyperhidrosis with botulinum-A toxin.
    Salmanpoor R, Rahmanian MJ.
    Int J Dermatol; 2002 Jul; 41(7):428-30. PubMed ID: 12121560
    [Abstract] [Full Text] [Related]

  • 12. Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis.
    Filosto M, Bertolasi L, Fincati E, Priori A, Tomelleri G, Chieregato G, Rizzuto N.
    Acta Neurol Belg; 2001 Jun; 101(2):121-3. PubMed ID: 11486559
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
    Frasson E, Brigo F, Acler M, Didonè G, Vicentini S, Bertolasi L.
    Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
    [No Abstract] [Full Text] [Related]

  • 14. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M, Plewig G, Hyperhidrosis Study Group.
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [Abstract] [Full Text] [Related]

  • 15. Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox.
    Glogau RG.
    Dermatol Surg; 1998 Aug; 24(8):817-9. PubMed ID: 9723044
    [Abstract] [Full Text] [Related]

  • 16. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Aug; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 17. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A, Sandroni L, Gesuita R, Giuliano A, Giuliodori K, Marconi B, Ganzetti G, Offidani A.
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [Abstract] [Full Text] [Related]

  • 18. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A--Dysport and Botox--assuming a ratio of 4:1.
    Sampaio C, Ferreira JJ, Simões F, Rosas MJ, Magalhães M, Correia AP, Bastos-Lima A, Martins R, Castro-Caldas A.
    Mov Disord; 1997 Nov; 12(6):1013-8. PubMed ID: 9399229
    [Abstract] [Full Text] [Related]

  • 19. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L, Slezinger A, Halem M, Vujevich J, Martin LK, Black L, Bryde J.
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [Abstract] [Full Text] [Related]

  • 20. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK, Hamm H, Lowe NJ, Botox Hyperhidrosis Clinical Study Group.
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.